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Researchers are using a variety of sophisticated approaches to identify genes that contribute 
to the development of alcoholism in humans or influence other alcohol-related traits. These 
strategies include linkage approaches, which can identify broad chromosomal regions that 
are likely to contain genes predisposing to the disorder, and association approaches, which 
test the association between a particular marker allele and a specific outcome. Animal studies 
using diverse strategies can also help identify genes or DNA regions that influence alcohol-
related traits in humans. The results of these analyses are likely to have implications for fields 
such as genetic counseling, gene therapy, and pharmacogenetics. KEY WORDS: genetic theory of 
AODU (alcohol and other drug use); genetic linkage; genetic correlation analysis; genetic screening 
method; genome; genetic trait; QTL (quantitative trait locus) mapping; mutation; AOD dependence 
potential; alcoholic beverage; DNA 
Alcoholism is one of the most common and costly health problems in the United States. 
Substantial evidence from family, twin, 
and adoption studies suggests that 
genetic factors play a role both in nor­
mal patterns of alcohol use and in alco­
hol use disorders (i.e., alcohol abuse and 
dependence). It is estimated that 
approximately 50 to 60 percent of the 
variance in alcohol dependence can be 
attributed to genetic factors (McGue 
1999). Researchers are currently 
attempting to identify the specific genes 
involved in patterns of alcohol use and 
alcohol dependence. These efforts are 
complicated by the complex nature of 
alcoholism and its development. Thus, 
although studies have convincingly 
demonstrated that genes play a role in 
the development of alcoholism, the 
same studies have also provided strong 
evidence for the importance of environ­
mental factors. The genetic and envi­
ronmental factors likely interact to 
result in disease development (for a 
more detailed discussion of those inter-
actions, see the article in this issue by 
Heath and Nelson, pp. 193–201). 
Despite these complexities, new 
developments in genetic technologies 
are enhancing scientists’ understanding 
of alcoholism. Several of these advances 
are described throughout this issue. 
This overview provides an introduction 
to some of the strategies currently being 
used to search for genes involved in 
alcoholism. It also discusses the impli­
cations of such basic genetic research 
for applied clinical practice. 
The Human Genome 
In most cells of the human body, the 
genetic information is contained in 46 
microscopic structures in the nucleus, 
called the chromosomes. The first 22 
chromosomes are present in pairs, and 
the 23rd pair consists of either 2 X chro­
mosomes (female) or an X and Y chro­
mosome (male) (see figure 1A). The 
chromosomes are inherited from the 
parents, with each parent providing 1 
set of 23 chromosomes. These chromo­
somes contain a large molecule called 
deoxyribonucleic acid (DNA) (see figure 
1B). The DNA consists of four building 
blocks called nucleotides that are ar­
ranged in a specific order. This sequence 
of nucleotides encodes the genetic infor­
mation necessary for the organism to 
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Figure 1 (A) A set of human chromosomes as seen under a microscope, containing 22 chromosome pairs (ordered according to 
size) and 2 sex chromosomes. In this case, the chromosomes were obtained from a male, as indicated by the presence of 
an X and a Y chromosome. (B) The structure of DNA. The DNA molecule is composed of two strands of building blocks that 
interact with each other. Each building block contains a chemical group called a base. There are four bases, adenine (A), 
cytosine (C), guanine (G), and thymine (T), in a sequence of paired bases. The base A on one strand always pairs with T on 
the opposite strand, and G always pairs with C. The sequence of these bases encodes the genetic information. (C) Micro-
satellite and single-nucleotide polymorphism (SNP) markers. Microsatellite markers are short sequences of two to four 
bases (in this example, the bases T and A) that are repeated several times. The number of repeats differs among individu­
als, creating many different versions (i.e., alleles) of the marker for genetic analyses. For SNP markers, only a single base 
differs between individuals (in this case, the base T is changed to a C); thus, there are only two possible alleles of the SNP. 
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develop and function. The DNA seg­
ments that determine those characteris­
tics of an individual that are inherited 
from one generation to the next are 
called genes. Large areas of the DNA, 
however, do not appear to contain 
genes. Some of these regions help regu­
late the activity (i.e., expression) of 
genes; for other DNA segments the 
function is still unknown. Nevertheless, 
these “noncoding” DNA regions can 
provide important tools for the study of 
the genome, as described next. 
Many variations in the DNA exist 
among the genes and noncoding DNA 
regions of different individuals. Such 
variants of a DNA sequence are called 
alleles. A DNA region for which several 
alleles exist is said to be polymorphic— 
that is, it exists in many forms. The 
identification of these variants has revo­
lutionized the study of genetics because 
it allows researchers to study the inheri­
tance of the alleles and to associate spe­
cific alleles with the presence of certain 
diseases. Several types of polymor­
phisms are commonly used for genetic 
analyses, including microsatellite mark­
ers and single-nucleotide polymor­
phisms (SNPs). Microsatellite markers 
are DNA sequences in which short 
motifs of two, three, or four nucleo­
tides are repeated several times, with 
the number of repetitions varying from 
person to person (see figure 1C). 
Microsatellite markers are typically 
found in noncoding DNA regions. 
SNPs consist of the exchange of single 
nucleotides in the DNA (see figure 1C) 
and can be found both in coding and 
noncoding DNA regions. If SNPs 
occur within a gene or within a DNA 
region controlling the activity of a 
gene, they can result in disease. How-
ever, many subtle changes in gene 
sequence—as well as many other DNA 
markers used in genetic analyses—have 
no apparent consequence. 
Review of Experimental 
Genetic Approaches 
Linkage Approaches 
To identify as yet unknown genes in­
volved in alcoholism and other disor­
ders, investigators can search the entire 
genetic material (i.e., genome) by test­
ing for linkage between polymorphic 
markers and the expression of the dis­
order or a related behavior. This means 
that, by studying families with several 
affected individuals, researchers analyze 
whether specific alleles of those markers 
are more commonly found in people 
with the disorder or behavior than in 
people without it. Using markers that 
are evenly spaced across all chromo­
somes, one can analyze the entire ge­
nome using this approach and thereby 
identify susceptibility genes with no, or 
only limited, prior knowledge about 
the mechanisms underlying the disease 
process. 
Studies using this approach initially 
focused on understanding the genetic 
mechanisms underlying disorders that 
are caused by defects in a single gene 
and for which the inheritance pattern 
could be clearly specified. These studies 
involved statistical tests called paramet­
ric linkage analyses, which use DNA 
markers to locate, or map, a disease 
gene to a particular chromosomal 
region. Such analyses led to the identi­
fication of the genes causing Hunting-
ton’s disease, cystic fibrosis, Duchenne 
muscular dystrophy, and hundreds of 
other genetic disorders.1 
Alcoholism, however, is a complex 
disease, with multiple genetic and envi­
ronmental factors contributing to the 
disorder. As a result, it may be impossi­
ble to specify a particular inheritance 
pattern of the disease. In this instance, 
researchers can use another type of sta­
tistical test called nonparametric link-
age analysis as a powerful tool to iden­
tify genes involved in the disorder. This 
statistical approach, which does not 
require a specific model of how a dis­
ease is inherited, typically involves 
identifying families with many affected 
family members who are thought to 
have inherited genes that increase the 
susceptibility to the disease. 
All nonparametric linkage analyses 
are based on a concept called identity 
by descent (IBD) marker allele sharing 
(see figure 2). If siblings inherit the 
Figure 2 Determination of identity by descent (IBD). For each nuclear family of two 
siblings and their parents, the illustration shows the genetic makeup of a 
marker with four variants (i.e., alleles). In the left panel, both siblings 
have inherited allele 1. However, the brother inherited allele 1 from the 
mother whereas his sister inherited allele 1 from the father. Therefore, 
they have no shared alleles (IBD = 0). In the middle panel, both siblings 
inherited allele 1 from the father (IBD = 1). In the right panel, both siblings 
inherited allele 2 from their father and allele 3 from their mother (IBD = 2). 
Siblings who are similar for a trait that is determined by a gene located 
close to the marker would be expected to share more alleles (i.e., have a 
higher IBD number) than siblings who are dissimilar for the trait. 
NOTE: Squares represent males and circles represent females. 
IBD=0 IBD=1 IBD=2 
1/2 1/3 1/2 3/4 
1/2 1/3 1/3 1/4 2/3 2/3 
3/41/2 
1A list of those disorders and genes can be found at the 
On-line Mendelian Inheritance in Man (OMIM) Web site at 
http://www3.ncbi.nlm.nih.gov/Omim/. 
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same marker allele from the same par­
ent, the allele is called IBD. If the 
marker being tested is in close physical 
proximity to a gene influencing the dis­
ease or trait under study, then siblings 
who are similar for the trait would be 
expected to share more IBD marker 
alleles. Conversely, siblings who are dis­
similar would be expected to exhibit 
fewer IBD marker alleles near the gene 
influencing the trait. More recently, 
nonparametric linkage methods have 
allowed the inclusion of more extended 
families beyond sibling pairs in the 
genetic analysis. Thus, more genetic 
information can be gained by studying 
more affected family members. Non-
parametric linkage analyses can be used 
to study both traits that exist in an 
“either-or” fashion (i.e., qualitative 
traits, such as having or not having a 
disease) and traits that vary in severity 
along a continuum (i.e., quantitative 
traits, such as quantity or frequency of 
alcohol use). 
Association Studies and Candidate 
Genes 
Whereas linkage analyses can identify a 
broad chromosomal region that is likely 
to contain a gene contributing to a disor­
der or behavior, association analyses are 
able to more accurately pinpoint the gene 
or genes that influence an outcome. One 
of the most commonly employed experi­
mental designs to identify genes con­
tributing to a disease is that of candidate 
gene analysis, which seeks to test the asso­
ciation between a particular allele of the 
candidate gene and a specific outcome. 
A candidate gene typically is chosen 
because it is suspected to play a role in 
the disorder, either because researchers 
have some information about the gene’s 
function that might be related to the dis­
ease or because the gene lies in a DNA 
region that has already been linked to the 
disorder through linkage studies. In the 
future, researchers hope to be able to con-
duct genomewide association studies in 
which SNPs spaced across the entire 
genome are tested to identify potential 
associations with a disease, rather than 
having to focus on candidate regions or 
genes. Such an approach, however, is 
likely to require 50,000 to 300,000 SNPs 
to test all DNA regions for associations 
with a disease or trait. The identification 
of large numbers of SNPs spaced through-
out the genome is already under way. In 
addition, researchers are currently develop­
ing new methods to make it feasible for 
genetic laboratories to determine a person’s 
DNA sequences (i.e., genotypes) for the 
large number of markers that will be 
required in genomewide association stud­
ies. Finally, new approaches to the statistical 
analysis of the vast amount of data resulting 
from such analyses are being developed, as 
studying such a large number of markers 
will create problems with multiple testing 
and increased potential for false positive 
results—problems that must be resolved 
before these strategies are feasible. 
Population-Based Association 
Studies. Many candidate gene studies 
use population-based association 
methods—that is, methods that com­
pare the genes of groups of people. 
For example, in alcoholism research 
such analyses would involve two 
samples: a group of alcoholic patients 
and a control group of nonalcoholic 
people. Ideally, the two groups would 
be matched with respect to numerous 
factors (e.g., age and ethnicity) so that 
they differ only in disease status. The 
investigators would then compare the 
frequencies of various alleles of a 
marker (e.g., an SNP) within or near 
the candidate gene (see figure 3A). 
Evidence of differences in allele 
frequencies between the two groups is 
typically interpreted as evidence that 
the candidate gene contributes to 
alcoholism susceptibility.2 
Because of their simplicity, popula­
tion-based association studies of candi­
date genes have been widely used and 
perhaps abused. There are several 
major problems with this approach in 
alcoholism research. The first problem 
is the choice of candidate gene. Numer-
2In theory, significant differences in allele frequencies 
between the alcoholics and nonalcoholics also may be the 
result of linkage disequilibrium between the candidate 
gene and the true disease susceptibility gene, which is 
located within the chromosomal region, but is distinct from 
the candidate gene. This means that the candidate gene is 
not actually the causative mutation, but it is so close to the 
disease-causing mutation that the candidate gene and the 
disease mutation tend to be transmitted together during 
the formation of eggs or sperm. 
ous biochemical pathways are likely to 
be involved in addictive behavior, 
including pathways related to alcohol 
metabolism. These pathways involve 
numerous enzymes and other 
molecules, and the genes encoding all 
of these molecules are therefore poten­
tial candidate genes. Thus, the number 
of candidate genes is large and increases 
daily with the application of new tech­
nologies to alcohol research. The sec­
ond problem is that with a disorder 
that involves multiple genes, such as 
alcoholism, the effects of each gene are 
probably small. Therefore, large sample 
sizes in multiple populations are often 
required to detect such genes. Third, 
spurious associations between certain 
alleles and the disorder are likely to 
show up if the two samples (i.e., alco­
holics and nonalcoholics) are not well 
matched with respect to important 
characteristics such as ethnicity. 
Family-Based Association Studies. 
To avoid the pitfalls of population-
based association studies, Spielman 
and Ewens (1996) developed a 
family-based association test—the 
transmission disequilibrium test 
(TDT). The primary advantage of the 
TDT is that it avoids the necessity of 
including a matched control sample. 
As originally proposed, the TDT 
analyzes a nuclear trio consisting of an 
affected person and his or her parents 
(see figure 3B). For these three 
people, researchers then determine 
the genotype of a marker in or near 
the candidate gene. If each parent 
carries two different alleles of the 
marker gene, then one allele from 
each parent will be transmitted to the 
affected offspring and one allele will 
not be transmitted. Those alleles that 
have been transmitted from the 
parents to the affected offspring are 
considered the “affected” sample, and 
the remaining alleles are used as 
“control” sample. Using the infor­
mation on the transmission of various 
alleles from many families, investigators 
can conduct statistical analyses to 
determine if a particular allele of the 
marker being tested is associated with 
disease development. Through the use 
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of such a “within-family” design, the 
control sample of alleles is perfectly 
matched to the affected sample of 
alleles because both samples are transmitted 
from the same two parents. To expand 
the use of the TDT, researchers 
recently have begun to apply it to 
other designs, such as family-based 
association tests that include data 
from both affected and unaffected 
siblings or from even more extended 
pedigrees. In addition, the test has been 
extended to the analysis of quantitative 
traits in addition to qualitative traits. 
Animal Studies 
The use of animal models to study 
genes related to alcohol use and its con-
sequences may provide important clues 
that will improve the efficiency of iden­
tifying genes underlying human alcohol-
Figure 3 (A) Design of case control studies. These analyses compare the frequen­
cies of alleles in a population of unrelated cases (e.g., alcoholics) and a 
population of control subjects (e.g., nonalcoholics). In the example shown 
here, a marker with three different alleles is assessed. The analysis 
shows that allele 1 occurs in 80 percent of the cases but only 20 percent 
of the control subjects. This finding suggests that allele 1 may be associ­
ated with disease susceptibility (e.g., susceptibility to alcoholism). (B) The 
transmission disequilibrium test (TDT) tests the hypothesis that a particu­
lar marker allele is more frequently transmitted to affected offspring from 
heterozygous parents. Again, a marker with three alleles is shown. In 
each of the three trios shown here, the father is heterozygous, carrying 
allele 2 and either allele 1 or allele 3. The mothers are either homozygous 
and therefore can transmit only one allele to their offspring (and are thus 
not informative for the TDT test) or heterozygous. Because in all three 
cases shown here the affected offspring carry allele 2 from the father, that 
allele is likely to be associated with the disorder. Information from many 
trios is tabulated to evaluate the statistical significance of the TDT test. 
NOTE: Squares represent males and circles represent females. 
1/3   1/2   1/3   2/3   1/1   1/2     2/2   1/1    1/3   1/2
1/3   2/2   2/3   2/3   3/3    1/2    2/2   3/3    2/3   2/2
A Cases 
Controls 
1/2 1/1 1/2 3/1 2/3 1/1 
1/2 3/2 1/2 
B 
seeking behavior. For example, researchers 
can use animal lines that are well char­
acterized with respect to alcohol-related 
behaviors to address genetic issues in 
populations that are genetically more 
homogeneous, because it is assumed 
that fewer genes are affecting the 
behavior of interest. Such an approach 
should make the isolation of candidate 
regions and genes faster and more effi­
cient. Animal studies also allow breed­
ing strategies that cannot be performed 
in humans. Another advantage of ani­
mal studies is the high degree of con­
servation of linked regions of genetic 
material across many species. This 
means that genes that are located close 
to each other on a given chromosome 
in humans are likely to be also located 
close to each other on one of the chro­
mosomes in mice, rats, or other ani­
mals. As a result, researchers who iden­
tify a certain DNA region in mice as 
playing a role in alcohol-related behav­
iors can infer the approximate location 
of the corresponding DNA region on a 
human chromosome. 
Most mouse studies of alcohol pref­
erence have used two mouse strains 
called C57BL/6 (B6) and DBA/2 (D2) 
that differ greatly in their alcohol pref­
erence and, consequently, alcohol con­
sumption. These two strains of mice 
are inbred, meaning that all animals 
from that strain are genetically identical 
and that for each gene, the animals 
carry two identical alleles (i.e., are 
homozygous). The consistent differ­
ence between the two strains in alcohol 
preference suggests that these strains 
carry different alleles at many of the 
genes influencing alcohol-drinking pat-
terns. These genes are often called 
quantitative trait loci (QTLs). 
Investigators have used a variety of 
breeding schemes to identify QTLs. For 
most of these schemes, the first step is 
to mate animals from the two progeni­
tor lines. The progeny are called F1 off-
spring. If the progenitors have differing 
alleles at the relevant QTLs for the trait 
of interest, then the F1 progeny must 
carry one copy of each allele at all these 
QTLs (i.e., they are heterozygous for 
these QTLs). Moreover, all of the F1 
animals are identical, both in their 
genetic makeup (i.e., their genotype) 
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and in their observable behaviors or 
traits (i.e., their phenotype). 
Starting with the F1 animals, re-
searchers can then use different breed­
ing schemes for subsequent analyses. 
One approach is the F2 design. For this 
approach, the F1 offspring are inter­
crossed—that is, brothers and sisters are 
mated—to generate an F2 population. 
In the F2 population, the alleles at the 
QTLs are said to be segregating, mean­
ing that each F2 animal has a different 
combination of alleles at the loci con­
tributing to the trait (see figure 4). This 
variability arises from the distribution 
of genetic material from parents to off-
spring as well as from a process called 
recombination that occurs during the 
specialized type of cell division that 
occurs when the egg and sperm are 
formed. Recombination is the exchange 
of genetic material between the two 
members of a chromosome pair. As a 
result, each individual of the F2 genera­
tion has a unique combination of the 
alleles found in the two progenitor 
strains. This diversity is reflected in the 
wide variation in the trait or behavior 
that is observed in the F2 offspring. 
Therefore, the F2 sample is ideal for 
performing analyses to determine the 
location of QTLs on the chromosomes 
(i.e., QTL mapping studies). 
Another breeding strategy that is 
commonly used in inbred mouse stud­
ies is the backcross design. In this 
approach, the F1 offspring of two 
inbred progenitors are mated back to 
one of the progenitor inbred strains 
Figure 4 Schematic illustration of the F2 breeding design used in genetic analyses, and the generation of recombinant inbred (RI) 
lines. For the F2 design, animals from the F2 generation are studied both for the trait under investigation and for their 
genetic makeup (i.e., genotype). Repeated inbreeding of the F2 animals results in the development of multiple RI lines. 
These lines differ in the composition of the genetic material inherited from the progenitors. However, all animals within an 
RI line are genetically identical. 
4. Sister–brother pairs of the F2 generation are 
mated. This inbreeding is repeated over several 
generations, eventually resulting in RI lines—that 
is, animals that are homozygous at each allele 
but possess unique recombinations of the genes 
that were polymorphic in the progenitors. These 
recombinations can be maintained by continued 
inbreeding. 
1. Two inbred strains (differentiated by colors) 
differ in numerous polymorphic regions and 
serve as progenitors for RI strains. 
2. Mating two inbred strains produces an F1 gener­
ation, in which all animals are identical. The F1 
animals have received one copy of each poly­
morphic region from each parent. 
3. F1 animals are mated to produce the F2 genera­
tion. As a result of the recombination of genetic 
material that occurs during the production of sperm 
and egg cells in the F1 generation, each animal 
of the F2 generation shows a unique pattern of 
the progenitors’ genes. 
Recombinant 
Inbred Lines 
F2 
F1 
Progenitors 
(Inbred strains) 
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(i.e., are backcrossed), to generate a 
backcross generation. Compared with 
an F2 sample, the backcross offspring 
will not be as diverse with respect to 
their genotype or their phenotype. 
An alternative approach that is also 
commonly used to identify QTLs, par­
ticularly using the B6 and D2 progeni­
tors, is the analysis of recombinant 
inbred (RI) lines. To generate RI lines, 
brothers and sisters from the F2 genera­
tion are mated, and this inbreeding is 
continued for 20 or more generations. 
As a result of the inbreeding, indepen­
dent RI lines are created where all ani­
mals within an RI line are genetically 
identical but all RI lines are genetically 
distinct from one another (see figure 4). 
Nevertheless, the RI lines are all related 
to each other because they were derived 
from the same two progenitors. The RI 
approach can be a particularly cost-
effective means to initially localize QTLs 
because the genotypes for many RI lines 
are known and readily available. Thus, 
an investigator only needs to test the 
trait(s) of interest in the animals of a set 
of RI lines and then correlate the trait 
results with the available genotypic data 
to identify putative QTLs. 
Although the RI approach requires 
less initial work than the F2 approach 
because sets of RI lines are commer­
cially available, the method is limited 
by the number of available RI lines. 
Thus, for a given progenitor cross, typ­
ically 20 to 40 RI lines exist, meaning 
that an investigator has a sample of 20 
to 40 different genotypes at a particular 
locus to assess for the trait of interest. 
In contrast, the F2 approach requires 
substantially more work, because both 
the phenotype and genotype must be 
determined for each animal as each F2 
animal has a different genotype. The 
benefit of this approach is that the 
resulting sample size available for QTL 
studies is much larger than with RI 
strains, often in the hundreds or thou-
sands. This large sample size allows for 
more powerful QTL mapping analyses. 
Studies using the B6 and D2 mice 
have identified QTLs contributing to a 
variety of alcoholism-related behaviors 
including alcohol preference, alcohol 
withdrawal, locomotor activation, and 
others (Belknap and Atkins 2001; Xu 
et al. 2002). (For more information on 
such studies, see the article in this issue 
by Phillips, pp. 202–207.) Other QTL 
studies have been conducted in two 
independently developed rat models of 
alcohol preference: (1) the alcohol pre­
ferring (P) and alcohol nonpreferring 
(NP) rats and (2) the high alcohol 
drinking (HAD) and low alcohol 
drinking (LAD) rats. These analyses 
have identified additional chromoso­
mal regions that are likely to contain 
genes influencing alcohol preference. 
Once QTL regions have been identi­
fied, most studies have proceeded to 
utilize planned breeding combined with 
analyses of the genotypes of relevant 
DNA markers in successive generations 
to develop congenic lines. These are 
lines of animals in which a DNA region, 
such as a QTL, is transferred into the 
genome of another strain through a 
series of planned matings. One can gen­
erate several related congenic lines that 
carry different or overlapping parts of 
the original QTL, which allows re-
searchers to substantially narrow down 
the DNA region that contains the rele­
vant gene(s) (see figure 5). 
Another strategy that has been 
employed in animals to identify genes 
related to a given trait is to randomly 
introduce changes (i.e., mutations) into 
the animals’ genome. In this approach, 
mutant lines of mice are produced by 
injecting male animals with a substance 
called ethyl-nitrosourea (ENU), which 
introduces DNA mutations through-
out the animals’ genome (De Angelis et 
al. 2000). These males are then mated 
to normal female mice, and the result­
ing F1 mice are tested with extensive 
screening protocols to identify those 
with abnormal traits. Mice with the 
Figure 5 Development of a congenic line in which a quantitative trait locus (QTL) 
from the donor line is being bred into the recipient line. The blue and 
white areas represent genetic material inherited from the two progenitors. 
The F1 offspring of a cross between donor and recipient carries approxi­
mately 50 percent of the genetic material from each parent. By repeatedly 
breeding the F1 animals and their offspring with the recipient line, the 
proportion of genetic material from the donor line becomes progressively 
less until only the QTL under investigation remains from the donor line. 
Donor Recipient 
QTL 
Full CongenicF10 
QTL 
F3 
F2 
F1 
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desired trait are then bred to a known 
mouse strain for genetic linkage analy­
ses to identify the genetic mutation 
causing the trait of interest. Because the 
order of the genes is very similar in 
mice and humans (and other mam­
mals), the location of a mutation iden­
tified in a mouse genome may help 
predict the location of the correspond­
ing gene in the human genome, sug­
gesting potential candidate genes for 
related traits in humans. The findings 
of such analyses can then be validated 
by studying animals in which the iden­
tified gene regions have been inacti­
vated (i.e., knockout animals) or have 
been introduced artificially (i.e., trans-
genic animals). (For more information 
on knockout and transgenic animals, 
see the article by Phillips, pp. 202–207.) 
Thus far, this technique has primar­
ily been used to identify genes that can 
cause a disease when they alone are 
mutated (i.e., single-gene mutations). 
By analyzing such randomly induced 
mutations on different genetic back-
grounds, researchers eventually may be 
able to also identify genes that only 
modify the risk for a disease. Although 
ENU mutagenesis was met with great 
enthusiasm when it was first intro­
duced, this technique has not yet been 
highly successful in mapping genes 
involved in complex traits, such as 
alcohol-related behaviors. 
From Basic Research to 
Applied Clinical Settings 
The techniques to identify alcohol-
related genes described in the preceding 
sections are still being developed and 
have yet to realize their full potential 
and identify genes contributing to alco­
holism susceptibility. Nevertheless, 
clinicians and researchers are already 
considering the implications of such 
studies and their findings for alcoholics 
and their families. These implications 
range from genetic counseling to gene 
therapy and pharmacogenetics. 
Genetic Counseling 
As challenging as it will be to identify 
genes involved in alcohol dependence, 
decisions regarding the use and applica­
tion of that knowledge will perhaps be 
even more challenging. How the infor­
mation regarding genetic susceptibility 
to alcoholism (and other disorders) will 
be conveyed to and used by the public 
is still undetermined. These issues are 
especially complex because any genes 
found to be involved in alcoholism are 
not likely to cause the disease directly 
but only increase or decrease alco­
holism susceptibility. Some of the 
issues that are likely to face alcohol 
researchers once they identify suscepti­
bility genes can be illustrated using the 
example of Alzheimer’s disease (AD) 
and the apolipoprotein E (ApoE) gene. 
Several alleles of this gene exist, one of 
which—the E4 allele—is associated 
with an increased risk for AD. People 
carrying at least one E4 allele have an 
estimated lifetime risk of AD of 
approximately 30 percent, whereas the 
risk of AD is only 9 percent in people 
who carry no E4 allele (Post et al. 
1997). However, most people who 
carry an E4 allele will never manifest 
the disease, and other people without 
an E4 allele can still develop AD. For 
this reason, screening people for the 
ApoE gene to determine their risk for 
AD has not been widely accepted in 
clinical practice, particularly for people 
who show no symptoms of the disease. 
A similar rationale might also apply 
to any potential genes identified as 
modifying the risk of alcoholism. 
However, alcoholism differs from AD 
in an important way: A person who 
knows that he or she is at risk for AD 
cannot take any measures to prevent the 
disease. People who know that they are 
at risk for alcoholism because of their 
genetic predisposition, in contrast, can 
make informed choices regarding their 
alcohol consumption and may thereby 
prevent the disorder. Accordingly, the 
identification of genes that predispose 
toward alcohol problems could be ben­
eficial for providing individual-specific 
risk assessment and could potentially 
allow some people at higher risk for 
alcoholism to take preventive measures 
(i.e., remain abstinent). 
Gene Therapy 
Gene therapy is an experimental treat­
ment in which normal genes are intro­
duced into the body’s cells to correct or 
modify the cell’s function. This tech­
nique was first employed successfully in 
1990 when it was used to treat severe 
combined immunodeficiency (SCID), 
a disease resulting from a deficiency of 
the enzyme adenosine deaminase 
(Anderson 1995). This enzyme nor­
mally converts a molecule called 
deoxyadenosine into another molecule 
called inosine. A person who inherits 
two defective alleles of the gene respon­
sible for adenosine deaminase produc­
tion cannot convert deoxyadenosine 
into inosine. This leads to the rapid 
accumulation of deoxyadenosine, which 
is then converted into a toxic product 
that kills white blood cells involved in 
fighting infections, resulting in an 
almost complete failure of the immune 
system and early death. To treat the 
disease, researchers removed white 
blood cells from affected patients, 
inserted a normal copy of the adeno­
sine deaminase gene into those cells, 
and reintroduced the modified cells 
into the body’s circulation. The modi­
fied cells then could produce sufficient 
adenosine deaminase to prevent 
deoxyadenosine accumulation. This 
kind of gene therapy is called somatic 
gene therapy.3 It does not cure the dis­
ease, however, because the modified 
blood cells have only a relatively short 
life span and are continuously replaced 
by new, defective blood cells. Therefore, 
the patients require repeated, lifelong 
treatments. 
However, scientists predict that in 
the future, genetic intervention in the 
reproductive tissues (i.e., ovaries and 
testes) may be possible in which the 
malfunctioning gene will be replaced 
with a properly functioning gene in the 
germ cells (i.e., eggs and sperm). This 
kind of gene therapy is called germline 
gene therapy. It would ensure that the 
normal gene, rather than the abnormal 
gene, is passed on to the offspring. Such 
3Somatic cells are those cells that make up most of the 
body. Because they are not used for reproduction, like the 
germ cells, somatic cells and their genetic information are 
not passed on to the offspring. 
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an approach will make gene therapy 
more efficient, because it frees not only 
the affected person but also his or her 
progeny from the burden of the genetic 
disease. Conversely, with current gene 
therapy one must treat affected people 
generation after generation. As of the 
year 2000, more than 300 protocols for 
gene therapy were submitted for review 
by the Center for Biologics Evaluation 
and Research, a division of the U.S. 
Food and Drug Administration.4 
The likelihood that gene therapy 
will be employed to modify the risk of 
alcohol dependence or other psychi­
atric disorders is unclear. Gene therapy 
is currently a complex and inefficient 
process, even when applied to disorders 
that result from a defect in a single 
gene. Gene therapy of disorders influ­
enced by multiple genes as well as envi­
ronmental factors is even less likely to 
be an efficient means of disease treat­
ment or prevention. 
Pharmacogenetics 
New genetic findings also may have a 
large impact on the pharmaceutical 
industry (Roses 2000). For many disor­
ders, treatment with medications is 
currently a trial-and-error process in 
which a patient’s physician attempts to 
determine what particular medicine 
and dose is most effective for that 
patient. For example, substantial vari­
ability exists in patients’ responses to a 
given medication, with some patients 
failing to respond to medicines that are 
effective in other patients. Similarly, 
some patients experience severe adverse 
side effects from medications that are 
well tolerated by other patients. The 
new area of pharmacogenetics promises 
to make this trial-and-error process a 
thing of the past. 
Pharmacogenetics is the application 
of knowledge about a person’s genetic 
makeup to predict his or her response 
to a particular drug. Thus, in the future, 
physicians may be able to conduct 
4A list of such protocols is available at http://www.fda.gov/ 
cber/gene.htm. 
genetic tests before prescribing a medi­
cation to determine whether the patient 
is likely to respond to the medication 
or to experience adverse side effects. To 
obtain this knowledge, researchers must 
compare large numbers of patients who 
do or do not respond to a medication, 
or who do or do not experience side 
effects. They must then analyze the 
DNA sequences of these differing pop­
ulations to identify differences that pre­
dict the patients’ responses. In this way, 
a person’s DNA sequence profile can be 
used to tailor treatment to his or her 
specific condition, even if the actual 
DNA sequences that are involved in 
the disorder are unknown. Some scien­
tists have argued that the discovery of 
DNA sequence variants relevant to 
pharmacogenetic issues raises fewer 
ethical and legal concerns than do 
genetic analyses that attempt to iden­
tify genes associated with a disease. 
This is because physicians would not 
test patients for the presence of specific 
genetic mutations predisposing to a 
disease, which would be subject to 
numerous ethical issues. Instead, physi­
cians would test for DNA sequence 
variants that predispose to certain med­
ical responses (and which may, for 
example, be related to the person’s 
metabolism). 
Conclusions 
This review has provided an introduc­
tion to the tools currently available in 
the search for genes involved in complex 
disorders, such as alcoholism, as well as 
to the issues that likely will be raised by 
the identification of those genes. This 
necessarily simplified overview should 
not convey the impression that the iden­
tification of such genes is straightfor­
ward. Indeed, many questions remain 
unanswered, including what study 
designs are most powerful, what analytic 
methods are best, and which alcoholism-
related traits are most appropriate for 
analysis. This issue of Alcohol Research & 
Health explores several of these topics. 
Many more questions will be raised 
once genes contributing to alcohol 
dependence are actually identified. 
However, the identification of such 
genes can also yield great benefits. Thus, 
these genes and their gene products may 
provide the essential data leading to 
early intervention for people who are at 
risk for alcoholism because they have 
inherited susceptibility genes. In addi­
tion, enhanced genetic knowledge may 
lead to the development of more effec­
tive treatment of alcoholic patients 
through a better understanding of the 
biochemical pathways involved in dis­
ease development. ■ 
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